IL1B and Hepatic fibrosis: In liver fibrosis models, such as those induced by dimethylnitrosamine (DMN), resveratrol reduces inflammatory cell infiltration and fibrosis, lowering MDA levels, increasing GPx and SOD levels, and inhibiting inflammatory mediators like NO, TNF-α, and IL-1β [177,178,179].